Veerhealth Care lands second ₹1.11 cr order from pharmacy chain
Repeat order for hair and oral care products confirms deepening ties with nationwide healthcare network; execution within 45 days.
— 5 earlier stories on Veerhealth Care Ltd. →What's new
- Repeat order worth ₹1.11 cr from the same nationwide pharmacy chain as the July 11 contract.
- Order covers hair care and oral care products; execution window of 45 days.
- Company reiterates FY27/FY28 guidance and confirms conclusion of preferential warrant allotment.
Why this matters
A second order from the same large client, even at the same value, signals the relationship is extending beyond a one-off trial. For a company with ₹61 cr market cap and thin profitability, consistent revenue from a national chain provides a visible near-term fillip, though at 3.4% of annual revenue the absolute size remains modest.
What we're watching
- Whether order frequency or size increases in subsequent quarters.
- Any disclosure of the client name when confidentiality expires.
- Impact of the ₹20.25 cr warrant proceeds on working capital and execution capacity.
The full read
Veerhealth Care has followed up its ₹1.11 crore first order from a nationwide pharmacy chain with a second order of identical value. The repeat contract for hair care and oral care products, to be executed within 45 days, confirms that the relationship is moving beyond a trial. The order represents 3.4% of annual revenue, comfortably exceeding nano-cap materiality thresholds. Small. But it provides near-term cash flow visibility. The company also wrapped up its ₹20.25 crore preferential warrant issue and reiterated its forward guidance. For a micro-cap with ₹61 crore market cap and a trailing P/E of 112, consistency from a national client is more valuable than size.
Questions answered
- How does this repeat order compare to Veerhealth's recent orders?
- It matches the ₹1.11 cr order disclosed on July 11 from the same chain. The company also bagged a ₹3.6 cr face-care order from an FMCG client in June 2026.
- What is the materiality of ₹1.11 cr for Veerhealth?
- The order equals 3.4% of annual revenue and 1.46% of market cap, crossing the company's materiality threshold. This is a genuine repeat contract from a large pharmacy chain.
- Why is the client's name withheld?
- The company cites confidentiality terms in its contract with the pharmacy chain. Such non-disclosure is common in initial or repeat supply agreements.
- Has Veerhealth concluded its preferential warrant allotment?
- Yes. The press release notes that the preferential allotment of warrants to promoters and non-promoters has been concluded. Earlier in July, the company raised ₹20.25 cr via 1 crore warrants at ₹20.25 each.
Veerhealth Care Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on NIYATILEAS →- 13 Jul 2026 · 2:55 PM IST Veerhealth Care lands second ₹1.11 cr order from pharmacy chain
- 2d ago Veerhealth Care lands ₹1.11 cr order from pharmacy chain, opens new channel
- 11d ago Veerhealth Care dilutes 31% of equity with ₹20.25 cr warrant issue
- 34d ago Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client
- 44d ago Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss